| Name | Title | Contact Details |
|---|
FibroGen is a research-based biotechnology company using its expertise in connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology to discover, develop, and commercialize novel therapeutics for serious unmet medical needs. FibroGen’s research team is committed to discovering novel therapies in areas of major unmet medical need. Our goal is to continue to provide pipeline candidates supported by rigorous data in well-characterized therapeutic settings. All of FibroGen`s therapeutic candidates have been internally developed based on FibroGen`s pioneering research in two important areas of biology, hypoxia-inducible factor (HIF) and connective tissue growth factor (CTGF).
ikaSystems is healthcare payers premier provider of enterprise-level cloud computing technologies for commercial, Medicare and Medicaid lines of business.
Particle Health is on a mission to solve the biggest problem facing the American healthcare system - data sharing.
Merit Health Systems is a Louisville, KY-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Biotechnology Business Consultants is a Ann Arbor, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.